摘要
Ischemia and reperfusion injury(IRI)is unavoidable in renal transplantation,and often causes acute renal failure,which is associated with prolonged hospitalization and high mortality.Therapies that attenuate IRI may lead to improvement in transplantation medicine.Funded by the National Natural Science Foundation of China,a research group led by Prof.Xia Qiang from Renji
Ischemia and reperfusion injury （IRI） is unavoidable in renal transplantation, and often causes acute renal failure, which is associated with prolonged hospitalization and high mortality. Therapies that attenu- ate IRI may lead to improvement in transplantation medicine.
